tradingkey.logo
搜索

Simulations Plus Inc

SLP
添加自选
13.340USD
-0.040-0.30%
收盘 05/15, 16:00美东报价延迟15分钟
269.54M总市值
亏损市盈率 TTM

Simulations Plus Inc

13.340
-0.040-0.30%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.30%

5天

-20.02%

1月

-5.52%

6月

-22.93%

今年开始到现在

-26.82%

1年

-57.69%

TradingKey Simulations Plus Inc股票评分

单位: USD 更新时间: 2026-05-15

操作建议

Simulations Plus Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名55/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价24.00。中期看,股价处于平稳状态。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Simulations Plus Inc评分

相关信息

行业排名
55 / 206
全市场排名
142 / 4482
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Simulations Plus Inc亮点

亮点风险
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
业绩高增长
公司营业收入稳步增长,连续3年增长32.90%
业绩增长期
公司处于发展阶段,最新年度总收入79.18M美元
业绩转亏
公司业绩转亏,最新年度亏损美元
估值低估
公司最新PE估值-4.27,处于3年历史低位
机构减仓
最新机构持股17.68M股,环比减少20.75%
HACAX持仓
明星投资者HACAX持仓,最新持仓市值4.60K
活跃度增加
近期活跃度增加,过去20天平均换手率0.17

分析师目标

根据 7 位分析师
买入
评级
24.000
目标均价
+79.37%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Simulations Plus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Simulations Plus Inc简介

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
公司代码SLP
公司Simulations Plus Inc
CEOO'Connor (Shawn M)
网址https://www.simulations-plus.com/
KeyAI